Workflow
Eastman(EMN)
icon
Search documents
Eastman Chemical (EMN) Shares Pop 17% in 3 Months: Here's Why
zacks.com· 2024-05-17 13:40
Forecast-topping earnings performance in the first quarter of 2024 and upbeat prospects have contributed to the rally in the company's shares. EMN's adjusted earnings of $1.61 per share trounced the Zacks Consensus Estimate of $1.41. Revenues of $2,310 million for the quarter also beat the Zacks Consensus Estimate of $2,259.2 million. Eastman is gaining from its actions to manage costs. It is expected to benefit from lower operating costs from its operational transformation program. EMN is taking actions to ...
Eastman (EMN) & Lubrizol to Enhance TPE Overmolding Adhesion
zacks.com· 2024-05-16 12:50
This was an exceptional chance for two premier material companies to capitalize on sustainable multi-material solutions that enable customer innovation and push the boundaries of consumer product experiences, Lubrizol noted. Shares of Eastman have gained 24.4% over the past year compared with a 1.1% rise of its industry. Eastman Chemical predicts uncertain primary demand in key markets and regions through the remainder of 2024. However, the company continues to gain from its innovation-driven growth approac ...
This is Why Eastman Chemical (EMN) is a Great Dividend Stock
Zacks Investment Research· 2024-05-10 16:47
Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors of ...
Eastman(EMN) - 2024 Q1 - Quarterly Report
2024-04-26 16:11
[FORWARD-LOOKING STATEMENTS](index=3&type=section&id=FORWARD%2DLOCKING%20STATEMENTS) This section provides a standard disclaimer regarding forward-looking statements, outlining their nature, the underlying assumptions, and the inherent risks and uncertainties - Forward-looking statements are defined as all statements, other than statements of historical fact, that may be made by Eastman Chemical Company from time to time, identifiable by terms such as 'anticipates', 'believes', 'estimates', 'expects', 'intends', 'may', 'plans', 'projects', 'forecasts', 'will', 'would', 'could', and similar expressions[10](index=10&type=chunk) - These statements are based on underlying assumptions as of the date made, including internal estimates, market conditions, management expectations, and economic conditions, and are subject to risks and uncertainties that could cause actual results to differ materially[11](index=11&type=chunk) - Investors are cautioned not to place undue reliance on forward-looking statements, which speak only as of the report date, and the Company undertakes no obligation to update them, except as legally required[12](index=12&type=chunk) [PART I. FINANCIAL INFORMATION](index=4&type=section&id=PART%20I.%20FINANCIAL%20INFORMATION) This part presents Eastman Chemical Company's unaudited consolidated financial statements and management's discussion and analysis for the first quarter of 2024 [ITEM 1. FINANCIAL STATEMENTS](index=4&type=section&id=ITEM%201.%20FINANCIAL%20STATEMENTS) This section presents Eastman Chemical Company's unaudited consolidated financial statements for the first quarter ended March 31, 2024, including statements of earnings, financial position, cash flows, and comprehensive notes detailing accounting policies, financial instruments, segment information, and other relevant disclosures [UNAUDITED CONSOLIDATED STATEMENTS OF EARNINGS, COMPREHENSIVE INCOME AND RETAINED EARNINGS](index=4&type=section&id=UNAUDITED%20CONSOLIDATED%20STATEMENTS%20OF%20EARNINGS%2C%20COMPREHENSIVE%20INCOME%20AND%20RETAINED%20EARNINGS) The unaudited consolidated statements of earnings show an increase in net earnings attributable to Eastman for Q1 2024 to $165 million, up from $134 million in Q1 2023, with diluted EPS rising to $1.39 from $1.12 | Metric | Q1 2024 (Millions USD) | Q1 2023 (Millions USD) | | :----------------------------------- | :--------------------- | :--------------------- | | Sales | $2,310 | $2,412 | | Cost of sales | $1,778 | $1,883 | | Gross profit | $532 | $529 | | Selling, general and administrative expenses | $191 | $191 | | Research and development expenses | $59 | $62 | | Asset impairments and restructuring charges, net | $11 | $22 | | Earnings before interest and taxes | $263 | $246 | | Net earnings attributable to Eastman | $165 | $134 | | Basic earnings per share attributable to Eastman | $1.40 | $1.13 | | Diluted earnings per share attributable to Eastman | $1.39 | $1.12 | | Comprehensive income attributable to Eastman | $156 | $119 | | Retained earnings at end of period | $9,559 | $9,013 | [UNAUDITED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION](index=5&type=section&id=UNAUDITED%20CONSOLIDATED%20STATEMENTS%20OF%20FINANCIAL%20POSITION) The unaudited consolidated statements of financial position indicate a slight increase in total assets to $14,748 million as of March 31, 2024, from $14,633 million at December 31, 2023 | Metric | March 31, 2024 (Millions USD) | December 31, 2023 (Millions USD) | | :----------------------------------- | :------------------------------ | :------------------------------- | | Cash and cash equivalents | $499 | $548 | | Total current assets | $3,638 | $3,481 | | Net properties | $5,535 | $5,548 | | Goodwill | $3,644 | $3,646 | | Total assets | $14,748 | $14,633 | | Total current liabilities | $2,618 | $2,576 | | Long-term borrowings | $4,340 | $4,305 | | Total liabilities | $9,140 | $9,103 | | Total Eastman stockholders' equity | $5,538 | $5,458 | | Total equity | $5,608 | $5,530 | [UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS](index=6&type=section&id=UNAUDITED%20CONSOLIDATED%20STATEMENTS%20OF%20CASH%20FLOWS) The unaudited consolidated statements of cash flows show a shift from net cash provided by operating activities in Q1 2023 to net cash used in Q1 2024, with a decrease in cash provided by financing activities | Metric | First Three Months 2024 (Millions USD) | First Three Months 2023 (Millions USD) | | :----------------------------------- | :----------------------------------- | :----------------------------------- | | Net cash used in operating activities | $(16) | $(2) | | Net cash used in investing activities | $(179) | $(252) | | Net cash provided by financing activities | $148 | $357 | | Net change in cash and cash equivalents | $(49) | $106 | | Cash and cash equivalents at end of period | $499 | $599 | [NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS](index=7&type=section&id=NOTES%20TO%20THE%20UNAUDITED%20CONSOLIDATED%20FINANCIAL%20STATEMENTS) These notes provide detailed disclosures on Eastman's accounting policies, financial instruments, debt, equity, and segment performance - Eastman adopted ASU 2022-03 (Fair Value Measurement) on January 1, 2024, which did not have a significant impact on the Company's financial statements[25](index=25&type=chunk) - The Company is currently evaluating the impact of recently issued ASUs, including ASU 2023-07 (Segment Reporting), ASU 2023-05 (Joint Venture Formations), and ASU 2023-09 (Income Taxes), which are effective for fiscal years beginning after December 15, 2023, 2024, and 2025 respectively[26](index=26&type=chunk)[27](index=27&type=chunk)[28](index=28&type=chunk) Inventories (Millions USD) | Category | March 31, 2024 | December 31, 2023 | | :---------------------- | :------------- | :---------------- | | Finished goods | $1,247 | $1,193 | | Work in process | $307 | $293 | | Raw materials and supplies | $636 | $618 | | Total inventories at FIFO or average cost | $2,190 | $2,104 | | Less: LIFO reserve | $421 | $421 | | Total inventories | $1,769 | $1,683 | Provision for Income Taxes and Tax Rate (Millions USD) | Metric | Q1 2024 | Q1 2023 | | :-------------------------- | :------ | :------ | | Provision for income taxes | $49 | $60 | | Tax rate | 23% | 31% | - In Q1 2024, Eastman issued **$750 million** aggregate principal amount of 5.625% notes due February 2034, with net proceeds of **$742 million**, and repaid **$198 million** of 7.25% debentures due January 2024[34](index=34&type=chunk) - The Company's **$1.50 billion** revolving credit agreement was amended in February 2024 to extend its maturity to February 2029. The **$300 million** 2024 Term Loan was repaid in Q1 2024[35](index=35&type=chunk)[36](index=36&type=chunk) Sales by Segment (Millions USD) | Segment | Q1 2024 | Q1 2023 | | :-------------------------- | :------ | :------ | | Advanced Materials | $748 | $742 | | Additives & Functional Products | $704 | $777 | | Chemical Intermediates | $523 | $589 | | Fibers | $331 | $303 | | Total Sales by Operating Segment | $2,306 | $2,411 | | Total Sales | $2,310 | $2,412 | Earnings (Loss) Before Interest and Taxes by Segment (Millions USD) | Segment | Q1 2024 | Q1 2023 | | :----------------------------------- | :------ | :------ | | Advanced Materials | $104 | $86 | | Additives & Functional Products | $109 | $124 | | Chemical Intermediates | $16 | $42 | | Fibers | $117 | $65 | | Total Earnings Before Interest and Taxes by Operating Segment | $346 | $317 | | Total Earnings Before Interest and Taxes | $263 | $246 | [ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=25&type=section&id=ITEM%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) This section provides management's perspective on Eastman's financial performance, condition, and liquidity for the first quarter of 2024 [Non-GAAP Financial Measures](index=26&type=section&id=Non%2DGAAP%20Financial%20Measures) Eastman utilizes non-GAAP financial measures to provide investors with a clearer understanding of period-over-period performance by excluding non-core, unusual, or non-recurring items - Management uses non-GAAP measures to evaluate performance by excluding transactions, costs, and losses or gains that do not directly result from core business operations or are unusual/non-recurring[101](index=101&type=chunk) - Non-core items include asset impairments, restructuring charges, acquisition/disposition costs, environmental costs for divested businesses, and mark-to-market adjustments for pension plans. Unusual items in Q1 2023 included an increase in state income taxes due to new guidance and insurance proceeds from a steam line incident[102](index=102&type=chunk) Non-Core and Unusual Items Excluded from Earnings (Millions USD) | Item | Q1 2024 | Q1 2023 | | :---------------------------------------------------- | :------ | :------ | | Asset impairments and restructuring charges, net | $11 | $22 | | Accelerated depreciation | — | $23 | | Steam line incident costs (insurance proceeds), net | — | $(8) | | Total non-core and unusual items impacting EBIT | $11 | $37 | | Total items impacting net earnings attributable to Eastman | $25 | $61 | [Overview](index=29&type=section&id=Overview) Eastman's innovation-driven growth model leverages technology platforms, application development, and market engagement for sustainable earnings growth and strong cash flow - Eastman's innovation-driven growth model focuses on world-class scalable technology platforms, differentiated application development capabilities, and market engagement to drive sustainable growth[111](index=111&type=chunk) Sales and EBIT (Millions USD) | Metric | Q1 2024 | Q1 2023 | | :------------------------------------------ | :------ | :------ | | Sales | $2,310 | $2,412 | | Earnings before interest and taxes | $263 | $246 | | Earnings before interest and taxes excluding non-core and unusual items | $274 | $283 | - Sales revenue decreased in Q1 2024 primarily due to lower selling prices, partially offset by higher sales volume attributed to reduced customer destocking[112](index=112&type=chunk) Net Earnings and EPS (Millions USD, except EPS) | Metric | Q1 2024 ($) | Q1 2024 (EPS) | Q1 2023 ($) | Q1 2023 (EPS) | | :------------------------------------------ | :---------- | :------------ | :---------- | :------------ | | Net earnings attributable to Eastman | $165 | $1.39 | $134 | $1.12 | | Adjusted net earnings | $190 | $1.61 | $195 | $1.63 | - Cash used in operating activities increased to **$16 million** in Q1 2024 from **$2 million** in Q1 2023[114](index=114&type=chunk) [Results of Operations](index=30&type=section&id=Results%20of%20Operations) Eastman's Q1 2024 results show a 4% decrease in sales, primarily driven by a 7% decline in selling prices, partially offset by a 3% increase in volume Sales Change Analysis (Millions USD) | Metric | Q1 2024 | Q1 2023 | Change ($) | Change (%) | | :-------------------- | :------ | :------ | :--------- | :--------- | | Sales | $2,310 | $2,412 | $(102) | (4)% | | Volume / product mix effect | | | $63 | 3% | | Price effect | | | $(164) | (7)% | | Exchange rate effect | | | $(1) | —% | Gross Profit (Millions USD) | Metric | Q1 2024 | Q1 2023 | Change (%) | | :---------------------------------- | :------ | :------ | :--------- | | Gross profit | $532 | $529 | 1% | | Gross profit excluding non-core and unusual items | $532 | $544 | (2)% | - Selling, general and administrative expenses remained unchanged at **$191 million** in Q1 2024 compared to Q1 2023, as higher variable compensation costs were offset by cost reduction initiatives[118](index=118&type=chunk) - Research and development expenses decreased by **5%** to **$59 million** in Q1 2024, primarily due to targeted cost reduction initiatives[119](index=119&type=chunk) Earnings Before Interest and Taxes (EBIT) (Millions USD) | Metric | Q1 2024 | Q1 2023 | Change (%) | | :------------------------------------------ | :------ | :------ | :--------- | | Earnings before interest and taxes | $263 | $246 | 7% | | EBIT excluding non-core and unusual items | $274 | $283 | (3)% | Net Earnings and Diluted EPS Attributable to Eastman (Millions USD, except EPS) | Metric | Q1 2024 ($) | Q1 2024 (EPS) | Q1 2023 ($) | Q1 2023 (EPS) | | :------------------------------------------ | :---------- | :------------ | :---------- | :------------ | | Net earnings and diluted EPS attributable to Eastman | $165 | $1.39 | $134 | $1.12 | | Adjusted net earnings and diluted EPS attributable to Eastman | $190 | $1.61 | $195 | $1.63 | [Summary by Operating Segment](index=34&type=section&id=Summary%20by%20Operating%20Segment) This section details the performance of Eastman's four operating segments: Advanced Materials, Additives & Functional Products, Chemical Intermediates, and Fibers [Advanced Materials Segment](index=34&type=section&id=Advanced%20Materials%20Segment) The Advanced Materials segment reported a 1% increase in sales for Q1 2024, driven by higher sales volume from reduced customer destocking in durables and electronics, despite lower selling prices Advanced Materials Segment Performance (Millions USD) | Metric | Q1 2024 | Q1 2023 | Change ($) | Change (%) | | :-------------------- | :------ | :------ | :--------- | :--------- | | Sales | $748 | $742 | $6 | 1% | | Volume / product mix effect | | | $32 | 4% | | Price effect | | | $(23) | (3)% | | EBIT | $104 | $86 | $18 | 21% | [Additives & Functional Products Segment](index=34&type=section&id=Additives%20%26%20Functional%20Products%20Segment) The Additives & Functional Products segment experienced a 9% decrease in sales in Q1 2024, primarily due to lower selling prices from cost pass-through contracts Additives & Functional Products Segment Performance (Millions USD) | Metric | Q1 2024 | Q1 2023 | Change ($) | Change (%) | | :-------------------- | :------ | :------ | :--------- | :--------- | | Sales | $704 | $777 | $(73) | (9)% | | Volume / product mix effect | | | $(8) | (1)% | | Price effect | | | $(67) | (8)% | | EBIT | $109 | $124 | $(15) | (12)% | [Chemical Intermediates Segment](index=35&type=section&id=Chemical%20Intermediates%20Segment) The Chemical Intermediates segment saw an 11% decrease in sales for Q1 2024, mainly due to lower selling prices driven by weak market conditions and reduced raw material costs Chemical Intermediates Segment Performance (Millions USD) | Metric | Q1 2024 | Q1 2023 | Change ($) | Change (%) | | :-------------------- | :------ | :------ | :--------- | :--------- | | Sales | $523 | $589 | $(66) | (11)% | | Volume / product mix effect | | | $13 | 2% | | Price effect | | | $(80) | (13)% | | EBIT | $16 | $42 | $(26) | (62)% | [Fibers Segment](index=35&type=section&id=Fibers%20Segment) The Fibers segment reported a 9% increase in sales for Q1 2024, driven by higher sales volume in textiles and increased selling prices in acetate tow Fibers Segment Performance (Millions USD) | Metric | Q1 2024 | Q1 2023 | Change ($) | Change (%) | | :------------------------------------------ | :------ | :------ | :--------- | :--------- | | Sales | $331 | $303 | $28 | 9% | | Volume / product mix effect | | | $23 | 7% | | Price effect | | | $6 | 2% | | EBIT | $117 | $65 | $52 | 80% | | EBIT excluding non-core items | $117 | $94 | $23 | 24% | [Sales by Customer Location](index=36&type=section&id=Sales%20by%20Customer%20Location) Eastman's total sales revenue decreased by 4% in Q1 2024 compared to Q1 2023 Sales Revenue by Customer Location (Millions USD) | Region | Q1 2024 | Q1 2023 | Change ($) | Change (%) | | :-------------------------- | :------ | :------ | :--------- | :--------- | | United States and Canada | $969 | $1,065 | $(96) | (9)% | | Europe, Middle East, and Africa | $659 | $709 | $(50) | (7)% | | Asia Pacific | $564 | $521 | $43 | 8% | | Latin America | $118 | $117 | $1 | 1% | | Total Eastman | $2,310 | $2,412 | $(102) | (4)% | - The overall sales decrease was primarily due to lower selling prices (down **7%**), particularly in the Europe, Middle East, and Africa region[146](index=146&type=chunk) - Higher sales volume (up **3%**), particularly in the Asia Pacific region, partially offset the decline in sales revenue[146](index=146&type=chunk) [Liquidity and Other Financial Information](index=37&type=section&id=Liquidity%20and%20Other%20Financial%20Information) Eastman maintains a strong liquidity position, expecting sufficient cash flows to meet short and long-term requirements, supported by an investment-grade credit rating - Management believes maintaining a financial profile that supports an investment grade credit rating is important to its long-term strategy and financial flexibility[149](index=149&type=chunk) Net Cash Provided by (Used in) Activities (Millions USD) | Activity | First Three Months 2024 | First Three Months 2023 | | :-------------------------- | :---------------------- | :---------------------- | | Operating activities | $(16) | $(2) | | Investing activities | $(179) | $(252) | | Financing activities | $148 | $357 | | Net change in cash and cash equivalents | $(49) | $106 | - Cash used in operating activities increased by **$14 million** in Q1 2024 primarily due to higher variable compensation payout and hedging settlement losses, partially offset by lower working capital[150](index=150&type=chunk) - The Company utilizes off-balance sheet accounts receivable factoring programs, selling **$698 million** and **$677 million** in invoices in Q1 2024 and Q1 2023, respectively, as a routine source of working capital funding[154](index=154&type=chunk) - Eastman's total borrowings were **$5.1 billion** at March 31, 2024. The company repaid **$198 million** of debentures and issued **$750 million** of new notes in Q1 2024[157](index=157&type=chunk)[158](index=158&type=chunk) - The **$1.50 billion** revolving credit agreement was extended to February 2029, and the **$300 million** 2024 Term Loan was repaid in Q1 2024[161](index=161&type=chunk)[162](index=162&type=chunk) Net Debt (Millions USD) | Metric | March 31, 2024 | December 31, 2023 | | :-------------------------- | :------------- | :---------------- | | Total borrowings | $5,080 | $4,846 | | Less: Cash and cash equivalents | $499 | $548 | | Net debt | $4,581 | $4,298 | - Capital expenditures were **$185 million** in Q1 2024, primarily for Advanced Materials segment methanolysis facilities and other growth initiatives. Expected 2024 capital expenditures are between **$700 million** and **$750 million**[167](index=167&type=chunk) - No shares were repurchased in Q1 2024 or Q1 2023 under the **$2.5 billion** 2021 authorization. As of March 31, 2024, **$785 million** has been used to repurchase **8,601,749 shares**[168](index=168&type=chunk)[182](index=182&type=chunk) [Critical Accounting Estimates](index=40&type=section&id=Critical%20Accounting%20Estimates) Eastman's critical accounting estimates, including those for asset impairment, environmental costs, pension benefits, litigation, and income taxes, remain consistent with those disclosed in the 2023 Annual Report on Form 10-K - Critical accounting estimates, including those related to impairment of long-lived assets, environmental costs, pension and other postretirement benefits, litigation and contingent liabilities, and income taxes, are consistent with the 2023 Annual Report on Form 10-K[169](index=169&type=chunk) - These estimates require management's most significant judgments, and actual results could differ from current estimates under different assumptions or conditions[169](index=169&type=chunk) [Recently Issued Accounting Standards](index=40&type=section&id=Recently%20Issued%20Accounting%20Standards) This section refers to Note 1, 'Significant Accounting Policies,' for information regarding the impact of recently issued accounting standards, indicating that management is currently evaluating their potential effects on the company's financial statements and disclosures - For information regarding the impact of recently issued accounting standards, refer to Note 1, 'Significant Accounting Policies,' in Part I, Item 1 of this Quarterly Report[170](index=170&type=chunk) [ITEM 3. Quantitative and Qualitative Disclosures About Market Risk](index=41&type=section&id=ITEM%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) Eastman is exposed to market risks from foreign currency exchange rates, commodity prices, and interest rates, which it manages through various strategies including hedging - Eastman is exposed to market risks from changes in foreign currency exchange rates, commodity prices, and interest rates, which are managed through pricing, inventory management, and hedging strategies[171](index=171&type=chunk) - A **10%** fluctuation in the euro currency rate would result in a **$232 million** impact on designated net investment values in foreign subsidiaries, generally offset by foreign currency changes in euro-denominated borrowings or cross-currency interest rate swaps[173](index=173&type=chunk) [ITEM 4. Controls and Procedures](index=41&type=section&id=ITEM%204.%20Controls%20and%20Procedures) Eastman's management, including the CEO and CFO, concluded that the company's disclosure controls and procedures were effective as of March 31, 2024, ensuring timely and accurate reporting - As of March 31, 2024, the Company's disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed was accumulated and communicated to management[175](index=175&type=chunk) - There has been no change in the Company's internal control over financial reporting during Q1 2024 that has materially affected, or is reasonably likely to materially affect, the internal control over financial reporting[176](index=176&type=chunk) [PART II. OTHER INFORMATION](index=42&type=section&id=PART%20II.%20OTHER%20INFORMATION) This part covers legal proceedings, risk factors, equity security sales, and other disclosures relevant to Eastman Chemical Company's operations [ITEM 1. LEGAL PROCEEDINGS](index=42&type=section&id=ITEM%201.%20LEGAL%20PROCEEDINGS) Eastman is routinely involved in various legal proceedings, including product liability, environmental, and intellectual property matters - Eastman is a party to various lawsuits, claims, investigations, and proceedings, including product liability, environmental, and intellectual property matters, handled in the ordinary course of business[178](index=178&type=chunk) - Management does not believe that the ultimate resolution of any pending legal matters will have a material adverse effect on the Company's overall financial position, results of operations, or cash flows[178](index=178&type=chunk) - The company's threshold for disclosing environmental legal proceedings involving a governmental authority is potential monetary sanctions of **$1 million** or more[178](index=178&type=chunk) [ITEM 1A. RISK FACTORS](index=42&type=section&id=ITEM%201A.%20RISK%20FACTORS) This section refers readers to the 'Risk Factors' section in Eastman's 2023 Annual Report on Form 10-K for a comprehensive discussion of material known risk factors that could adversely affect the company's business, financial condition, or results of operations - For information regarding the Company's material known risk factors, refer to 'Risk Factors' in Part I, Item 1A of the Company's 2023 Annual Report on Form 10-K[180](index=180&type=chunk) [ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS](index=43&type=section&id=ITEM%202.%20UNREGISTERED%20SALES%20OF%20EQUITY%20SECURITIES%20AND%20USE%20OF%20PROCEEDS) Eastman's Board of Directors authorized a $2.5 billion common stock repurchase program in December 2021 - The Company's Board of Directors authorized the repurchase of up to **$2.5 billion** of common stock in December 2021[182](index=182&type=chunk) - No shares were repurchased during the first quarter of 2024[182](index=182&type=chunk) Stock Repurchase Program Status | Metric | As of March 31, 2024 | | :----------------------------------- | :------------------- | | Total shares repurchased under 2021 authorization | 8,601,749 | | Total value repurchased under 2021 authorization | $785 million | | Remaining authorization | $1,715 million | | Total authorization | $2.5 billion | [ITEM 5. OTHER INFORMATION](index=43&type=section&id=ITEM%205.%20OTHER%20INFORMATION) This section confirms that none of Eastman's directors or officers adopted, modified, or terminated any Rule 10b5-1 or non-Rule 10b5-1 trading arrangements during the first quarter of 2024 - No directors or officers adopted, modified, or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement during the first quarter of 2024[183](index=183&type=chunk) [ITEM 6. EXHIBITS](index=44&type=section&id=ITEM%206.%20EXHIBITS) This section provides an index of all exhibits filed as part of the Form 10-Q report, including corporate governance documents, debt instrument forms, certifications from the CEO and CFO, and Inline XBRL data files - The Exhibit Index lists all exhibits filed as part of this report, including Amended and Restated Certificate of Incorporation, Bylaws, Form of 5.625% Notes due 2034, Rule 13a-14(a) Certifications, Section 1350 Certifications, and Inline XBRL documents[186](index=186&type=chunk) [SIGNATURES](index=44&type=section&id=SIGNATURES) This section contains the formal certification of the Quarterly Report on Form 10-Q, duly signed on behalf of Eastman Chemical Company by William T. McLain, Jr., Executive Vice President and Chief Financial Officer, on April 26, 2024 - The report is signed by William T. McLain, Jr., Executive Vice President and Chief Financial Officer, on behalf of Eastman Chemical Company[189](index=189&type=chunk) - The signing date for the report is April 26, 2024[189](index=189&type=chunk)
Eastman(EMN) - 2024 Q1 - Earnings Call Transcript
2024-04-26 16:03
Financial Data and Key Metrics Changes - The company reported a strong start to Q1 2024, with a notable volume-driven performance compared to the previous year, indicating recovery from prior destocking challenges [72][106] - The capital expenditures (CapEx) are projected to be in the range of $700 million to $750 million for the year, with share repurchases expected between $200 million to $300 million [148] Business Line Data and Key Metrics Changes - Advanced Materials segment showed a strong recovery, with a 15% sequential increase in durable goods from Q4, indicating a rebound in demand [91][106] - The additives and functional products segment experienced a slight decline of 1%, while advanced materials grew by 4%, showcasing mixed performance across business lines [89][106] Market Data and Key Metrics Changes - The company noted that the European market remains attractive long-term, despite current regulatory uncertainties and inflationary pressures affecting capital expenditures [4][33] - The demand for propylene derivatives has been impacted by recent outages in the industry, but the company expects to navigate these challenges effectively [22][106] Company Strategy and Development Direction - The company is focused on expanding its specialty applications, particularly in the Tritan product line, while optimizing value between PET and specialty products as new plants are developed [15][37] - The strategy includes a commitment to chemical recycling, with ongoing projects aimed at addressing local recycling needs and reducing carbon footprints [56][69] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding the economic outlook, stating that while the fundamentals are not expected to worsen, geopolitical uncertainties could pose risks to forecasts [17][38] - The company is confident in its ability to meet recycled content targets, despite challenges in contract negotiations with consumer brands [54][47] Other Important Information - The company is experiencing mechanical issues at its methanolysis plant, which are being addressed to ensure reliable operations moving forward [75][76] - The Longview project is expected to achieve significant returns, with ongoing negotiations regarding funding and project scope adjustments [138][148] Q&A Session Summary Question: Can you provide details on the methanolysis plant's performance? - The plant is currently running and producing on-spec material, but is facing mechanical issues that are being resolved [18][75] Question: How is the company managing CapEx in light of inflation? - The company has a plan to manage capital expenditures effectively, focusing on customer contracts and EU policy [35][33] Question: What is the outlook for the France project? - The project is still moving forward, but there are timing delays due to customer and cost issues that need to be resolved [62][87] Question: How committed are consumer brands to recycled content? - Many brands are highly committed to increasing recycled content in their packaging, but contract negotiations are taking longer than expected [53][54] Question: What are the expectations for volume growth in the coming quarters? - The company anticipates a mix of restocking and stable demand, with potential upside as markets stabilize [135][106]
Eastman's (EMN) Q1 Earnings and Sales Surpass Estimates
Zacks Investment Research· 2024-04-26 11:51
Eastman Chemical Company (EMN) reported first-quarter 2024 earnings of $1.39 per share, reflecting a rise of 24.1% from the year-ago quarter's figure of $1.12.EMN posted adjusted earnings of $1.61 per share, down 1.2% from the year-ago quarter figure of $1.63. It surpassed the Zacks Consensus Estimate of $1.41.The company’s revenues in the first quarter were $2,310 million, which beat the Zacks Consensus Estimate of $2,259.2 million. Sales decreased around 4.2% from $2,412 million reported in the prior-year ...
Eastman Chemical (EMN) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks Investment Research· 2024-04-25 23:31
For the quarter ended March 2024, Eastman Chemical (EMN) reported revenue of $2.31 billion, down 4.2% over the same period last year. EPS came in at $1.61, compared to $1.63 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $2.26 billion, representing a surprise of +2.25%. The company delivered an EPS surprise of +14.18%, with the consensus EPS estimate being $1.41.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and h ...
Eastman(EMN) - 2024 Q1 - Quarterly Results
2024-04-25 20:23
[Corporate Overview](index=1&type=section&id=Corporate%20Overview) Eastman reported strong Q1 2024 sequential earnings growth, driven by completed inventory destocking and Kingsport methanolysis facility revenue, despite a slight sales decline | (In millions, except per share amounts) | 1Q2024 | 1Q2023 | | :--- | :--- | :--- | | Sales revenue | $2,310 | $2,412 | | EBIT | $263 | $246 | | Adjusted EBIT* | $274 | $283 | | Earnings per diluted share | $1.39 | $1.12 | | Adjusted earnings per diluted share* | $1.61 | $1.63 | | Net cash used in operating activities | $(16) | $(2) | - CEO Mark Costa highlighted that **inventory destocking is complete** across most key end markets, including consumer durables, building and construction, and personal care[4](index=4&type=chunk) - The company achieved on-spec production and revenue generation at its Kingsport methanolysis facility, which is expected to contribute approximately **$75 million of incremental EBITDA** in 2024 compared to 2023[4](index=4&type=chunk)[8](index=8&type=chunk) - The U.S. Department of Energy selected Eastman to receive up to **$375 million** for a second molecular recycling project in Longview, Texas[8](index=8&type=chunk) [Segment Performance](index=1&type=section&id=Segment%20Results%201Q%202024%20versus%201Q%202023) Q1 2024 segment performance was mixed, with Advanced Materials and Fibers growing, while Additives & Functional Products and Chemical Intermediates declined [Advanced Materials](index=1&type=section&id=Advanced%20Materials) Advanced Materials sales increased 1% to **$748 million** due to higher volume/mix, leading to increased EBIT from improved price-cost dynamics - Sales revenue increased **1%** due to **4%** higher sales volume/mix, partially offset by **3%** lower selling prices[5](index=5&type=chunk) - Volume growth was driven by reduced customer inventory destocking in specialty plastics for consumer durables, though partially offset by destocking in the medical end market[6](index=6&type=chunk) - EBIT increased, primarily due to improved price-cost and higher sales volume/mix[7](index=7&type=chunk) [Additives & Functional Products](index=2&type=section&id=Additives%20%26%20Functional%20Products) Additives & Functional Products sales decreased 9% to **$704 million** due to lower prices and volume, resulting in decreased EBIT from higher manufacturing costs - Sales revenue decreased **9%**, resulting from **8%** lower selling prices and **1%** lower sales volume/mix[9](index=9&type=chunk) - Lower selling prices were mainly due to cost-pass-through contracts, with volume/mix down as growth in coatings and care additives was offset by declines in specialty fluids and agriculture[10](index=10&type=chunk) - EBIT decreased due to lower sales volume/mix and higher manufacturing costs from planned maintenance shutdowns[11](index=11&type=chunk) [Fibers](index=2&type=section&id=Fibers) Fibers sales grew 9% to **$331 million** driven by higher volume/mix and prices, with EBIT increasing due to improved price-cost - Sales revenue increased **9%**, comprised of **7%** higher sales volume/mix and **2%** higher selling prices[11](index=11&type=chunk) - Volume/mix growth was primarily driven by a **double-digit percentage increase** in textiles, thanks to strong adoption of Naia™ sustainable textile products[12](index=12&type=chunk) - EBIT increased as a result of higher sales volume/mix and improved price-cost[13](index=13&type=chunk) [Chemical Intermediates](index=2&type=section&id=Chemical%20Intermediates) Chemical Intermediates sales decreased 11% to **$523 million** due to lower prices, partially offset by volume, resulting in decreased EBIT from lower spreads - Sales revenue decreased **11%**, driven by **13%** lower selling prices, partially offset by **2%** higher sales volume/mix[13](index=13&type=chunk) - Lower selling prices were a result of weak market conditions and lower variable costs, while sales volume/mix increased slightly due to growth in the plasticizers product line[14](index=14&type=chunk) - EBIT decreased due to lower spreads[15](index=15&type=chunk) [Cash Flow and 2024 Outlook](index=2&type=section&id=Cash%20Flow%20and%20Outlook) Eastman used **$16 million** in Q1 2024 operating cash and returned **$95 million** to shareholders, reaffirming 2024 adjusted EPS and cash from operations guidance [Cash Flow](index=2&type=section&id=Cash%20Flow) In Q1 2024, **$16 million** cash was used in operating activities, and **$95 million** was returned to stockholders via dividends, prioritizing organic growth and shareholder returns | Cash Flow Item | Amount (in millions) | | :--- | :--- | | Cash used in operating activities | $(16) | | Dividends paid to stockholders | $95 | [2024 Outlook](index=2&type=section&id=2024%20Outlook) Eastman maintains its full-year 2024 adjusted EPS outlook of **$7.25 to $8.00** and **$1.4 billion** cash from operations, anticipating benefits from innovation and Kingsport methanolysis | 2024 Full-Year Outlook | Value | | :--- | :--- | | Adjusted EPS | $7.25 - $8.00 | | Cash from Operations | Approx. $1.4 billion | - The company expects to benefit from its innovation-driven growth model and revenue from the Kingsport methanolysis facility, primarily in the second half of the year[17](index=17&type=chunk) [Financial Tables](index=5&type=section&id=Financial%20Tables) This section presents detailed Q1 2024 financial statements, including Statements of Earnings, sales breakdowns, GAAP to non-GAAP reconciliations, Cash Flows, and net debt [Table 1 – Statements of Earnings](index=6&type=section&id=Table%201%20%E2%80%93%20Statements%20of%20Earnings) In Q1 2024, Eastman reported sales of **$2,310 million**, a decrease from Q1 2023, while net earnings increased to **$165 million** (**$1.39 per diluted share**) | (Dollars in millions) | Q1 2024 | Q1 2023 | | :--- | :--- | :--- | | Sales | $2,310 | $2,412 | | Gross profit | $532 | $529 | | Earnings before interest and taxes | $263 | $246 | | Net earnings attributable to Eastman | $165 | $134 | [Table 2 – Segment and Geographic Sales Information](index=7&type=section&id=Table%202%20%E2%80%93%20Segment%20and%20Geographic%20Sales%20Information) This section details sales performance, showing 5% sequential growth, a 4% year-over-year decline, and varied geographic performance with Asia Pacific growing [Table 2A – Segment Sales Information](index=7&type=section&id=Table%202A%20%E2%80%93%20Segment%20Sales%20Information) Q1 2024 total sales were **$2,310 million**, with Advanced Materials (**$748 million**) and Additives & Functional Products (**$704 million**) being the largest revenue segments | Sales by Segment (Dollars in millions) | Q1 2024 | Q1 2023 | Q4 2023 | | :--- | :--- | :--- | :--- | | Advanced Materials | $748 | $742 | $705 | | Additives & Functional Products | $704 | $777 | $640 | | Chemical Intermediates | $523 | $589 | $513 | | Fibers | $331 | $303 | $346 | | **Total Eastman Chemical Company** | **$2,310** | **$2,412** | **$2,207** | [Table 2B – Sales Revenue Change](index=8&type=section&id=Table%202B%20%E2%80%93%20Sales%20Revenue%20Change) Total company revenue decreased **4%** year-over-year due to price, while sequentially increasing **5%** from Q4 2023 driven by volume/mix Sales Revenue Change: Q1 2024 vs. Q1 2023 | Segment | Revenue % Change | Volume / Mix Effect | Price Effect | | :--- | :--- | :--- | :--- | | Advanced Materials | 1% | 4% | (3)% | | Additives & Functional Products | (9)% | (1)% | (8)% | | Chemical Intermediates | (11)% | 2% | (13)% | | Fibers | 9% | 7% | 2% | | **Total Company** | **(4)%** | **3%** | **(7)%** | Sales Revenue Change: Q1 2024 vs. Q4 2023 | Segment | Revenue % Change | Volume / Mix Effect | Price Effect | | :--- | :--- | :--- | :--- | | Advanced Materials | 6% | 6% | (1)% | | Additives & Functional Products | 10% | 8% | 1% | | Chemical Intermediates | 2% | 1% | 1% | | Fibers | (4)% | (7)% | 3% | | **Total Company** | **5%** | **4%** | 0% | [Table 2C – Sales by Customer Location](index=8&type=section&id=Table%202C%20%E2%80%93%20Sales%20by%20Customer%20Location) In Q1 2024, the United States and Canada were the largest market with **$969 million** in sales, while Asia Pacific sales grew year-over-year | Sales by Customer Location (Dollars in millions) | Q1 2024 | Q1 2023 | | :--- | :--- | :--- | | United States and Canada | $969 | $1,065 | | Europe, Middle East, and Africa | $659 | $709 | | Asia Pacific | $564 | $521 | | Latin America | $118 | $117 | | **Total Eastman Chemical Company** | **$2,310** | **$2,412** | [Table 3 – Non-GAAP EBIT Reconciliations and Margins](index=9&type=section&id=Table%203%20%E2%80%93%20Non-GAAP%20EBIT%20Reconciliations%20and%20Margins) This section reconciles GAAP to non-GAAP adjusted EBIT, showing Q1 2024 total company adjusted EBIT of **$274 million** with an **11.9%** margin, and Fibers achieving **35.3%** [Table 3A - Segment, Other, and Company Non-GAAP EBIT Reconciliations](index=9&type=section&id=Table%203A%20-%20Segment%2C%20Other%2C%20and%20Company%20Non-GAAP%20EBIT%20Reconciliations) Q1 2024 reported company EBIT of **$263 million** was adjusted by **$11 million** for impairments to reach a non-GAAP EBIT of **$274 million** | (Dollars in millions) | Q1 2024 GAAP EBIT | Adjustments | Q1 2024 Adjusted EBIT | | :--- | :--- | :--- | :--- | | **Total Company** | **$263** | **$11** | **$274** | [Table 3B - Segment Non-GAAP EBIT Margins](index=11&type=section&id=Table%203B%20-%20Segment%20Non-GAAP%20EBIT%20Margins) In Q1 2024, the Fibers segment achieved the highest adjusted EBIT margin at **35.3%**, a notable increase from Q1 2023, with total company margin at **11.9%** | Adjusted EBIT Margin | Q1 2024 | Q1 2023 | | :--- | :--- | :--- | | Advanced Materials | 13.9% | 11.6% | | Additives & Functional Products | 15.5% | 16.0% | | Chemical Intermediates | 3.1% | 7.1% | | Fibers | 35.3% | 31.0% | | **Total Company** | **11.9%** | **11.7%** | [Table 4 – Non-GAAP Net Earnings and EPS Reconciliations](index=12&type=section&id=Table%204%20%E2%80%93%20Non-GAAP%20Net%20Earnings%20and%20EPS%20Reconciliations) This section reconciles GAAP to non-GAAP earnings, showing Q1 2024 adjusted EPS of **$1.61** (down from Q1 2023), with a forecasted full-year adjusted effective tax rate of **16%** [Table 4A – Non-GAAP Earnings Reconciliations](index=12&type=section&id=Table%204A%20%E2%80%93%20Non-GAAP%20Earnings%20Reconciliations) In Q1 2024, GAAP net earnings of **$165 million** (**$1.39/share**) were adjusted to non-GAAP net earnings of **$190 million** (**$1.61/share**) | (per diluted share) | Q1 2024 | Q1 2023 | | :--- | :--- | :--- | | As reported (GAAP) | $1.39 | $1.12 | | Non-GAAP (Adjusted) | $1.61 | $1.63 | [Table 4B - Adjusted Effective Tax Rate Calculation](index=13&type=section&id=Table%204B%20-%20Adjusted%20Effective%20Tax%20Rate%20Calculation) The Q1 2024 effective tax rate was **23%**, with the forecasted full-year adjusted effective tax rate remaining consistent at **16%** | Tax Rate | Q1 2024 | Q1 2023 | | :--- | :--- | :--- | | Effective tax rate | 23% | 31% | | Forecasted full year adjusted effective tax rate | 16% | 16% | [Table 5 – Statements of Cash Flows](index=14&type=section&id=Table%205%20%E2%80%93%20Statements%20of%20Cash%20Flows) For Q1 2024, net cash used in operating activities was **$16 million**, with **$179 million** used in investing and **$148 million** provided by financing | (Dollars in millions) | First Three Months 2024 | First Three Months 2023 | | :--- | :--- | :--- | | Net cash used in operating activities | $(16) | $(2) | | Net cash used in investing activities | $(179) | $(252) | | Net cash provided by financing activities | $148 | $357 | | **Cash and cash equivalents at end of period** | **$499** | **$599** | [Table 6 – Total Borrowings to Net Debt Reconciliations](index=14&type=section&id=Table%206%20%E2%80%93%20Total%20Borrowings%20to%20Net%20Debt%20Reconciliations) As of March 31, 2024, Eastman's net debt increased to **$4,581 million** from year-end 2023, calculated from total borrowings of **$5,080 million** less **$499 million** in cash | (Dollars in millions) | March 31, 2024 | December 31, 2023 | | :--- | :--- | :--- | | Total borrowings | $5,080 | $4,846 | | Less: Cash and cash equivalents | $499 | $548 | | **Net debt** | **$4,581** | **$4,298** |
Eastman Chemical: Cyclical But Resilient
Seeking Alpha· 2024-04-25 07:34
Fahroni An essential characteristic of any diversified or actively managed portfolio is the presence of cyclical stocks at various points in market cycles. The structural volatility of the business cycles provides ample opportunity to generate a decent alpha. The following most desirable characteristics we look for in a cyclical stock are to ascertain the resilient nature of the business and management prudence to understand if the company has the right kind of foundations to withstand the cyclical head ...
Eastman Chemical (EMN) Could Be a Great Choice
Zacks Investment Research· 2024-04-24 16:46
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments. Cash flow can come from bond interest, interest from other types of investments, and of course, dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a ...